{
    "root": "9f3c9287-0615-4d2e-823d-673b33586e06",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Methamphetamine Hydrochloride",
    "value": "20240930",
    "ingredients": [
        {
            "name": "METHAMPHETAMINE HYDROCHLORIDE",
            "code": "997F43Z9CV",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_35340"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 102",
            "code": "PNR0YF693Y",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        }
    ],
    "indications": {
        "text": "methamphetamine hydrochloride tablets indicated treatment attention deficit hyperactivity disorder ( adhd ) pediatric patients 6 years age older .",
        "doid_entities": [
            {
                "text": "attention deficit hyperactivity disorder (DOID:1094)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1094"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 administer methamphetamine hydrochloride tablets orally daily two divided doses daily . avoid late evening due risk insomnia . ( 2.2 ) \u2022 recommended starting 5 mg twice daily . ( 2.3 ) \u2022 daily may increased 5 mg increments weekly intervals depending response . ( 2.3 ) \u2022 recommended range 20 mg 25 mg daily . ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "methamphetamine hydrochloride tablets , usp supplied 5 mg tablets supplied round , white off-white , biconvex , debossed tablet \u201c 54 \u201d one side \u201c 681 \u201d side . ndc 0054-0389-25 : bottle 100 tablets storage handling recommended storage : store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) . [ usp controlled room temperature . ] dispense tight , light resistant , child-resistant container defined usp/nf .",
    "adverseReactions": "methamphetamine hydrochloride tablets contraindicated patients : \u2022known hypersensitivity amphetamine , components methamphetamine hydrochloride tablets . hypersensitivity angioedema anaphylactic reported patients treated amphetamine products [ ( 6 ) ] . \u2022taking monoamine oxidase inhibitors ( maois ) , within 14 days following discontinuation treatment maois ( including maois linezolid intravenous methylene blue ) , risk hypertensive crisis [ ( 7.1 ) ] .",
    "indications_original": "Methamphetamine hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older.",
    "contraindications_original": "\u2022 Administer methamphetamine hydrochloride tablets orally once daily or in two divided doses daily. Avoid administration late in the evening due to the risk of insomnia. ( 2.2 ) \u2022 Recommended starting dosage is 5 mg once or twice daily. ( 2.3 ) \u2022 Daily dosage may be increased in 5 mg increments at weekly intervals depending on clinical response. ( 2.3 ) \u2022 The recommended dosage range is 20 mg to 25 mg daily. ( 2.3 )",
    "warningsAndPrecautions_original": "Methamphetamine Hydrochloride Tablets, USP \n                  \n                     How Supplied\n                     5 mg tablets are supplied as a round, white to off-white, biconvex, debossed tablet with \u201c54\u201d on one side and \u201c681\u201d on the other side.\n                  NDC 0054-0389-25: Bottle of 100 tablets \n                  \n                     Storage and Handling\n                     Recommended Storage:Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F). [See USP Controlled Room Temperature.]\n                  Dispense in a tight, light resistant, child-resistant container as defined in the USP/NF.",
    "adverseReactions_original": "Methamphetamine hydrochloride tablets are contraindicated in patients with:\n                  \n                     \n                        \u2022known hypersensitivity to amphetamine, or other components of methamphetamine hydrochloride tablets.  Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions (6)]. \n                     \n                        \u2022taking monoamine oxidase inhibitors (MAOIs), or within 14 days following discontinuation of treatment with an MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of the risk of hypertensive crisis [see Drug Interactions (7.1)].",
    "drug": [
        {
            "name": "Methamphetamine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_35340"
        }
    ]
}